Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients-Reference-Cited by-同舟云学术

Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients

Published:2019-09-24 Issue:18 Volume:3 Page:2764-2777
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Inamoto Yoshihiro¹^ORCID,White Jennifer²,Ito Reiko¹,Martin Paul J.²³,Fatobene Giancarlo²,Ito Ayumu¹^ORCID,Tanaka Takashi¹^ORCID,Kurosawa Saiko¹,Kim Sung-Won¹,Bar Merav²³,Sorror Mohamed L.²³,Sandmaier Brenda M.²³,Lee Stephanie J.²³^ORCID,Fukuda Takahiro¹,Flowers Mary E. D.²³

Affiliation:

1. Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan;

2. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and

3. Department of Medicine, University of Washington, Seattle, WA

Abstract

Key Points Late acute and chronic GVHD are experienced differently across the races in terms of incidence, sites, severities, and clinical outcomes. Japanese patients have more frequent liver and less frequent gastrointestinal involvement with late acute and NIH chronic GVHD.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/3/18/2764/1223293/advancesadv2019000386.pdf

Reference31 articles.

1. Chronic graft-versus-host disease;Lee;Biol Blood Marrow Transplant,2003

2. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium;Pidala;Blood,2011

3. Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease;Inamoto;Haematologica,2014

4. How we treat chronic graft-versus-host disease;Flowers;Blood,2015

5. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report;Filipovich;Biol Blood Marrow Transplant,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An open‐label study of belumosudil, a selective ROCK2 inhibitor, as second or subsequent line of therapy for steroid‐dependent/steroid‐resistant chronic GVHD;American Journal of Hematology;2024-06-27

2. Utilization and outcome disparities in allogeneic hematopoietic stem cell transplant in the United States;European Journal of Haematology;2023-10-30

3. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD;Blood Advances;2023-08-11

4. Chronic graft-versus-host disease in pediatric patients: Differences and challenges;Blood Reviews;2023-07

5. Chronic Graft-versus-host Disease-associated Membranous Nephropathy Following Bone Marrow Transplantation, Successfully Treated with Rituximab;Internal Medicine;2023-01-15